Internal Medicine, Gastroenterology · Lakeland, FL
NPI
1699987800
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
805 East Garden Street
Lakeland, FL, 33805
Phone (863) 802-1111
Groups this clinician bills Medicare through
Medicare paid, 2024
$116K
1,374 services
Medicare patients, 2024
399
Average age 71
Drug cost, 2024
$638K
617 prescriptions
Company payments, 2025
$149
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mahmudul Haque was code 99232 (hospital e&m - subsequent), 334 times for 114 patients. In total Mahmudul Haque billed 1,374 services in 44 codes, and Medicare paid $116K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-10-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 334 | 114 | $61.44 | $21K |
| 99214 Office E&M - Established | Office | 258 | 150 | $86.76 | $22K |
| 88305 Surgical Pathology Examination | Office | 137 | 55 | $44.39 | $6,081 |
| 99204 Office E&M - New | Office | 135 | 135 | $113.55 | $15K |
| 99222 Hospital E&M - Initial | Facility | 113 | 106 | $102.14 | $12K |
| 43239 Upper GI Endoscopy | Facility | 62 | 61 | $65.54 | $4,063 |
| 88313 Surgical Pathology Examination | Office | 48 | 26 | $52.94 | $2,541 |
| 88312 Surgical Pathology Examination | Office | 31 | 18 | $84.03 | $2,605 |
| 99223 Hospital E&M - Initial | Facility | 26 | 25 | $135.06 | $3,511 |
| 45385 Colonoscopy - Lesion Removal | Facility | 21 | 21 | $186.74 | $3,922 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 15 | 15 | $179.54 | $2,693 |
| 43251 Upper GI Endoscopy | Facility | 14 | 14 | $141.02 | $1,974 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 14 | 14 | $164.61 | $2,305 |
| 45378 Lower GI Endoscopy - Other | Facility | 13 | 13 | $118.66 | $1,543 |
| 43246 Upper GI Endoscopy | Facility | 13 | 12 | $150.62 | $1,958 |
By year: 2022 $152K for 1,831 services; 2023 $116K for 1,414 services; 2024 $116K for 1,374 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 137 | 55 | $44.39 | $6,081 |
| 88313 Surgical Pathology Examination | 48 | 26 | $52.94 | $2,541 |
| 88312 Surgical Pathology Examination | 31 | 18 | $84.03 | $2,605 |
Medicare prescription drug claims, 2024
In 2024, the drug Mahmudul Haque prescribed most often to Medicare patients was Pantoprazole Sodium, with 98 prescriptions and refills. In total Mahmudul Haque wrote 617 Medicare prescriptions that cost $638K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 98 | 125 | 70 | $532 |
| Famotidine Generic | 65 | 117 | 35 | $799 |
| Furosemide Generic | 65 | 135 | 41 | $257 |
| Dicyclomine Hcl Generic | 62 | 99 | 50 | $1,566 |
| Spironolactone Generic | 60 | 127 | 36 | $1,276 |
| Desipramine Hcl Generic | 31 | 39 | 18 | $877 |
| Sofosbuvir-Velpatasvir Sofosbuvir/Velpatasvir | 23 | 23 | Under 11 | $184K |
| Sucralfate Generic | 14 | 16 | Under 11 | $1,038 |
| Prednisone Generic | 13 | 15 | Under 11 | $49.71 |
| Lactulose Generic | 13 | 20 | Under 11 | $293 |
| Octreotide Acetate Generic | 13 | 13 | Under 11 | $3,957 |
| Epclusa Sofosbuvir/Velpatasvir | 12 | 12 | Under 11 | $290K |
| Omeprazole Generic | 11 | 18 | Under 11 | $107 |
Brand drugs: 94 claims; generic drugs: 523 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mahmudul Haque $149 ($149 in general payments such as food, travel and fees) from 3 companies. The largest payer was Madrigal Pharmaceuticals with $67.1.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.